XGX Pharma ApS
CVR 32289290 · Private limited company (ApS) · Active · Low risk
XGX Pharma ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 16 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 30.8m and a net result of DKK 16.1m.
Bankruptcy risk for XGX Pharma ApS
0.2 × the average (1.41%) · higher risk than 49% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 32289290
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (17 years)
- Address
- Frederiksgade 11, st. th
1265 København K - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 400k
- Employees
- 2 (2018)
- Auditor
- KPMG P/S
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 16 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 55.9% |
| Current ratio | 175% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 53 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 32.3m | DKK 16.0m | DKK 8.1m |
| Net profit | DKK 16.1m | DKK 4.5m | DKK 461k |
| Equity | DKK 30.8m | DKK 18.7m | DKK 14.3m |
| Total assets | DKK 55.1m | DKK 39.0m | DKK 29.6m |
| Short-term debt | DKK 20.3m | DKK 13.3m | – |
| Tax owed | DKK 3.3m | – | – |
| Avg. employees | 0 | 4 | – |
Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring · KPMGStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 177 | ||
| 1 Jan 2024 – 31 Dec 2024 | 87 | ||
| 1 Jan 2023 – 31 Dec 2023 | 169 | ||
| 1 Jan 2022 – 31 Dec 2022 | 177 | ||
| 1 Jan 2021 – 31 Dec 2021 | 172 | ||
| 1 Jan 2020 – 31 Dec 2020 | 90 | ||
| 1 Jan 2019 – 31 Dec 2019 | 99 | ||
| 1 Jan 2018 – 31 Dec 2018 | 126 | ||
| 1 Jan 2017 – 31 Dec 2017 | 170 | ||
| 1 Jan 2016 – 31 Dec 2016 | 158 | ||
| 1 Jan 2015 – 31 Dec 2015 | 183 | ||
| 1 Jan 2014 – 31 Dec 2014 | 177 | ||
| 1 Jan 2013 – 31 Dec 2013 | 188 | Late | |
| 1 Jan 2012 – 31 Dec 2012 | 159 | ||
| 1 Jan 2011 – 31 Dec 2011 | 169 | ||
| 14 Jul 2009 – 31 Dec 2010 | 144 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Mohammad Sohail Asghar | ||
| Board | Per Anders Larnholt | Current | |
| Board | Johan Frödin | Current | |
| Board | Mohammad Sohail Asghar | ||
| Board | Per Ludvigsen | ||
| Board | Jens-Nikolaj Schøier | ||
| Board | Lars Karlsmose | ||
| Board | Rolf Eckersberg | ||
| Board | Mohammad Sohail Asghar | ||
| Owner (100%) | Unimedic Pharma AB | Current | |
| Owner (50%) | MSA ApS | ||
| Owner (50%) | Chrisyda Management Ltd. | ||
| Owner (50%) | Jens-Nikolaj Schøier | ||
| Owner (50%) | Schøier Holding ApS | ||
| Owner (33%) | MSA ApS | ||
| Owner (10%) | JCNS Holding ApS | ||
| Owner (33%) | Schøier Holding ApS | ||
| Owner (5%) | E CONSULT ApS | ||
| Owner (33%) | MSA ApS | ||
| Owner (20%) | JCNS Holding ApS | ||
| Owner (33%) | Schøier Holding ApS | ||
| Auditor | KPMG P/S | Current | |
| Auditor | Kreston CM Statsautoriseret Revisions interessentskab | ||
| Auditor | REVISIONSFIRMAET WOIREMOSE & PARTNER REGISTRERET REVISIONSANPARTSSELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | Kreston CM Statsautoriseret Revisions interessentskab | ||
| Founder | MSA ApS | Current |
The CEOs' other companies
Mohammad Sohail Asghar – 5 other companies
- Frederiksstaden Pharma ApS Active
- HB MEDICAL SCANDINAVIA A/S Fusioneret
- MSA ApS Active
- SAIM Medical ApS Active
- Vautia Therapeutics ApS Active
Address history (5 moves)
| Frederiksgade 11, st. th, 1265 København K | |
| c/o Ordnung, Tuborgvej 5, 2900 Hellerup | |
| c/o Regus House, Automatikvej 1, 3., 2860 Søborg | |
| Bistrup Hegnsvej 1B, 3460 Birkerød | |
| Rolighedsvej 10, 3. tv, 1958 Frederiksberg C | |
| Børsgade 8, 1., 1215 København K |
Former names
| XGX Pharma ApS | – now |
| VITAL PHARMA NORDIC ApS | – |
| VITAL PHARMA NORDIC HOLDING ApS | – |
Employees per year
Other companies at the same address
- AKTIESELSKABET UNIVERSAL REPRO SERVICE Bankrupt
- SFPN INVEST ApS Bankrupt
- A69 ApS Active
- ACORN SPV ApS Active
- AxCap Founders GP ApS Active
- AxCap GP ApS Active
- AxCap Management 1 ApS Active
- BALDERSGADE 48 ApS Active
- BRUNDE STORCENTER ApS Fusioneret
- Bellidavej 20 Holding ApS Active
- Birch SPV ApS Opløst
- CARL BERNHARDSVEJ NR. 9-11 ApS Active
- CD Projects ApS Active
- CEDAR ApS Opløst
- Charlie Tango Management ApS Active
- D14 ApS Active
- DIG Global A/S Active
- DIG Global GP ApS Active
- DIG Investment Management Denmark A/S Active
- Dragon SPV ApS Opløst
- EJENDOMSSELSKABET AF 19.10.1953 ApS Active
- ELM SPV ApS Active
- Ejendomsselskabet Frederiksgade 11 ApS Active
- Entreprenørselskabet af 3/2 2016 ApS Fusioneret
- F7 ApS Active
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about XGX Pharma ApS
Has XGX Pharma ApS gone bankrupt?
No, XGX Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of XGX Pharma ApS?
Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.
Who is the auditor of XGX Pharma ApS?
XGX Pharma ApS most recently used KPMG P/S.
When was XGX Pharma ApS founded?
XGX Pharma ApS was founded on 14 July 2009.
What is the equity of XGX Pharma ApS?
Equity was DKK 30.8m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.